Viral Rhinitis, Influenza, Rhinosinusitis and Pharyngitis PDF

3/26/24, 10:32 PM Viral Rhinitis, Influenza, Rhinosinusitis and Pharyngitis absorption of tetracyclines or quinolones; avoid concomitant therapy. The use of intranasal zinc has been associated with long-term or permanent loss of smell and is not recommended.​ For comparative ingredients of nonprescr...

3/26/24, 10:32 PM Viral Rhinitis, Influenza, Rhinosinusitis and Pharyngitis absorption of tetracyclines or quinolones; avoid concomitant therapy. The use of intranasal zinc has been associated with long-term or permanent loss of smell and is not recommended.​ For comparative ingredients of nonprescription products, consult the Compendium of Products for Minor Ailments—Herbal and Natural Health Products: Single Entity; Vitamin and Mineral Products: Single Entity. Considerations in Special Populations Children Acetaminophen or ibuprofen may be used for relief of aches and pains or fever >38.5°C. Avoid ASA due to its association with Reye syndrome. See Fever for more information on the management of fever. Nonprescription cough and cold remedies should be avoided in children 23–40 kg: 60 mg BID PO × 5 days >40 kg: 75 mg BID PO × 5 days Nausea, vomiting. Safety in pregnancy not established but currently recommended as first-line agent in pregnant women. For dose adjustments in renal impairment, consult the Compendium of Therapeutic Choices: Influenza. Prophylaxis:​ ​ ​ Adults and children ≥13 y: 75 mg once daily PO Children: ≥1 y and ≤15 kg: 30 mg once daily PO >15–23 kg: 45 mg once daily PO >23–40 kg: 60 mg once daily PO >40 kg: 75 mg once daily PO Duration of prophylaxis is variable; used for the duration of the outbreak https://cps-pharmacists-ca.login.ezproxy.library.ualberta.ca/print/new/documents/MA_CHAPTER/en/v_rhinitis_flu_sinusitis_pharyngitis 14/19